156 results about "Indometacin" patented technology

The invention provides a composition and a method for inducing mesenchymal stem cells to be differentiated to cartilage cells. The composition comprises 20-80 uM of L-ascorbic acid-2-phosphate, 2-10 ng/ml of TGF beta 3, 50-150 nM of dexamethasone, 10-50 ug/ml of vitamin C, 10-50 ug/ml of proline, 0.5-5 ug/ml of indometacin, 1xITS+1premix and 0.5-10 ug/ml of chlormadinone ester. The combination when being used as an inducer of a culture medium can improve differentiation activity and differentiation directionality.

A method of altering specificity of cyclooxygenase-inhibiting compounds that have a COOH moiety by changing the various COOH containing compounds, such as indomethacin, into ester derivatives or into secondary amide derivatives.

The invention discloses a multifunctional microemlusion gel preparation and a preparation process thereof, and belongs to the technical field of medicines. The preparation mainly comprises bulk pharmaceutical chemicals (such as non-steroidal anti-inflammatory drugs-diclofenac sodium, ibuprofen, indometacin, antifungal drugs-ornidazole, antiviral drugs-ganciclovir, hormone drugs-dexamethasone, local anesthesia drugs-lidocaine and irritants-menthol), a cationic polymer and a microemlusion, can further comprise gel or a thickener, and can be used for transdermal drug delivery and local drug delivery. The preparation process is simple, convenient, good in stability and pollution-free. Compared with existing cream and gel, the preparation has the advantages that a novel action mechanism is adopted, the accumulative penetration amount of unit area of drugs is remarkably increased, a certain slow-release effect is achieved, and the drug delivery frequency and the drug delivery amount can be reduced; a chemical penetration enhancer and a conventional preservative are not added, a certain bacterial inhibition effect is achieved, the skin irritation is avoided, and the use safety of the drugs is improved.

The invention discloses a hot-melt extrusion process for preparing an indometacin quick release preparation from multi-element auxiliary materials and belongs to the field of pharmacy. The method comprises the following steps of: crushing indometacin and medicinal auxiliary materials, and after screening the powder with a 60 to 120-mesh sieve, uniformly mixing the powder into a physical mixture; according to the melting points or the glass transition temperatures of the medicament and the auxiliary materials, setting the extrusion temperature of a double-screw hot melt extruder to be between 50 and 150 DEG C, after the extrusion temperature reaches the preset temperature, starting a screw, adding the prepared physical mixture into the extruder, and extruding the physical mixture into strips through the screw; and after crushing the strips, screening the powder with a 20 to 80-mesh sieve to obtain medicinal solid dispersoid particles or powder. The auxiliary materials comprise the following components in percentage by weight: 10 to 90 percent of polymer, 5 to 50 percent of plasticizer, 0 to 10 percent of lubricant, 0 to 5 percent of surfactant and 0 to 20 percent of disintegrant. A sugar alcohol with a relatively low softening point or melting point, and the like, serving as the plasticizer, is added into the polymer with a relatively high softening point or melting point so as to reduce the extrusion temperature and make the extrusion process easy. The prepared indometacin solid dispersoid has the characteristic of quickly dissolving out.

The invention discloses the application of koumine to the preparation of medicines for treating chronic pains and belongs to the application of gelsemium alkaloid monomer. The analgesic experiments of the koumine on chronic pains of animals prove that the koumine has potent dose-dependent analgesic effect, the analgesic potency is superior to that of the classical antipyretic-analgesic and anti-inflammatory drugs which are aspirin and indomethacin, the therapeutic index of the koumine is much higher than that of the total alkaloids of gelsemium, the koumine possibly has no tolerance, no addiction and little side effect, which indicates that the koumine has potent and low-toxicity analgesic effect, the mechanism of action of the koumine is possibly different from those of clinically common opium analgesics or aspirin analgesics, the koumine and the pharmaceutically acceptable salt thereof have the application of preparing of the medicines for treating chronic pains and have no serious disadvantages of the clinically common analgesics and can be developed into a novel analgesic which has potent analgesic effect in treating chronic pains such as inflammatory pain, neuropathic pain, cancer pain and the like, has no tolerance and addiction and little side effect, thus the koumine has bright industrialization prospect.

The present invention provides a mesenchymal stem cell adipogenic differentiation culture medium, and belongs to the technical field of stem cells. The mesenchymal stem cell adipogenic differentiation culture medium comprises a DMEM/F12 culture medium, and further comprises FBS with a volume percentage of 5-50%, glutamine with a volume percentage of 0.5-5%, antibiotic with a volume percentage of 0.5-5%, 50-500 [mu]M indometacin, 50-500 nM insulin, 5-50 nM dexamethasone, 0.5-5 [mu]M 3-isobutyl-1-methylxanthine, and 0.05-0.5 [mu]M fasudil hydrochloride. The mesenchymal stem cell adipogenic differentiation culture medium of the present invention has advantages of high inducing efficiency and the like.

The invention belongs to the medicine category, and in particular discloses a mild moxibustion plaster. The mild moxibustion plaster comprises the following components in parts by weight: 40-50 parts of blumea oil, 20-30 parts of indometacin, 30-45 parts of heating element, 5-10 parts of medical rubber and 2-5 parts of back lining cloth, wherein the heating element comprises reduced iron powder, active carbon, saline water and far infrared ceramic powder on a ratio by weight of reduced iron powder to active carbon to saline water to far infrared ceramic powder as (8-14):(3-6):1:(5-8). According to the mild moxibustion plaster disclosed by the invention, the moxibustion method is combined with plasters, so that a mild moxibustion plaster is developed; and the mild moxibustion plaster is used for moxibustion treatment, therefore the disadvantages of inconsistent moxibustion time, less human body absorption and large raw material waste and the like in the conventional moxibustion method are completely overcome.

The invention provides a medicine composition containing matrine class alkaloid, a preparation method and pharmaceutical applications. The medicine composition is the combination of the matrine class alkaloid and inflammation-resisting pain-relieving class medicines. The inflammation-resisting pain-relieving medicine comprises the non-steroidal inflammation-resisting medicines of aspirin, acetaminophen, indometacin, ibuprofen, oxyphenbutazone, naproxen, mefenamic acid, diclofenac sodium, celecoxib, rofecoxib, valdecoxib and the like and also comprises the vegetable inflammation-resisting pain-relieving class medicines of escin, ferulic acid, berberine, wilfordine, ephedrine and the like and the pain-relieving class medicines of morphia, demerol and the like. The matrine class alkaloid and one or various of the inflammation-resisting pain-relieving class medicines can form a medicine composition used for the pharmaceutical applications of resisting cold, allaying a fever and treating the swelling and pain of the bone joint and the muscle, rheumatic diseases, cardiovascular diseases, arteriosclerotic diseases, tumors, anaphylactic diseases, senile dementia, mosquito bite, insect bite and the like.

The invention relates to an indometacin sustained release tablet, a preparation method thereof, as well as a release controlling method and standard. The indometacin sustained release tablet is prepared from the following components in percentage by weight: 8.0-25.0% of indometacin, 25.0-40.0% of hydroxypropyl methyl cellulose, 12.0-25.0% of microcrystalline cellulose K15M-CR, 8.0-15.0% of microcrystalline cellulose, 15.0-25.0% of lactin, 1.0-6.0% of gum acacia and 0.5-1.5% of magnesium stearate. A full-powder direct compression process is adopted; the production process is simplified; the methoxyl content of prepared mid-product methoxyl is 8.2-18%; and the propoxyl content is 2.6-7.8%. The quality of the indometacin sustained release tablet disclosed by the invention reaches the standard; a reference product has release similarity; mass control is carried out before production; rework can be reduced; the production cost is saved; the energy consumption is reduced; and the production efficiency is improved.

The invention relates to a composite slow-release agent, wherein it contains indomethacin, aminoglucose salt, slow-release material and other findings, while their ratios are 5-45%, 20-80%, 1-75%, and the left is findings. Its preparation comprises that mixing indomethacin and/or aminoglucose salt, and slow-release material and/or packs, then adding other findings, using general slow-release technique to obtain one or several skeleton or mould-contoro slow-release agent. The invention can be made into particle, oral, tablet or capsule. The invention can keep stable blood drug density in 8-36h, reduce side effect.

The invention provides an indometacin and albuterol suppository and a preparation method of the suppository; the suppository comprises effective dose of indometacin, effective dose of albuterol, a dispersing agent, emulsifier and a molding agent. The preparation method comprises the steps of dissolving the indometacin and the albuterol in the dispersing agent, then mixing with the molten molding agent and the emulsifier, and homogenizing to obtain the suppository. The suppository provided by the invention is featured with smooth production and uniform quality; and auxiliary materials do not influence content detection; wherein content detection recovery rate of the albuterol reaches 97%, and content uniformity A+1.8S is less than 10, and is superior to a requirement that content uniformity A+1.8S of a suppository is less than 25 (Department 2 of Chinese Pharmacopoeia 2005 edition, Page 75 of Appendix XE); and layering and precipitation do not appear after the suppository is subjected to a challenge test at 45 degrees centigrade for 72 hr.

The invention discloses an indometacin amorphous particle, a particle drug preparation, a preparation method and application. The preparation method includes the following steps: dissolving indometacin in water containing hydrophilic polymer and alkalizer or low-concentration alcohol water solution; controlling pH of the solution to be 7.5-9; under a mixing condition, adding acidifier until pH of the solution is 2.5-4.5 to form mixed liquid containing the indometacin amorphous particle, and performing separation to obtain the indometacin amorphous particle. Dissolution performance of the indometacin amorphous particle and the particle drug preparation is improved obviously, the indometacin amorphous particle and the particle drug preparation are high in bioavailability if being taken orally, high in stability, simple in preparation method, free of toxic solvent residue, safe, reliable and good in market prospect.

The invention discloses a method for researching an abirritation mechanism of Chinese herbal medicinal ingredients of Xinhuang tablets and a pharmaceutical composition comprising the Xinhuang tablets. The method for researching the abirritation mechanism comprises the following steps of preparing a Xinhuang tablet sample and an indometacin sample in a weight ratio of 95:2, establishing a living acetic acid writhing reaction model and a living planta reaction model to evaluate the drug treatment effects and the synergic index of the Chinese herbal medicinal ingredients of the Xinhuang tablets and indometacin, and establishing a naloxone occlusion reaction model to evaluate the influence of occlusion on the analgesic effect. Based on the research on the mechanism of action, and in order to improve the treatment effect for analgesia, the invention also provides an analgesic composition which is composed of the Xinhuang tablets and ketorolac tromethamine. The method is used for measuring the abirritation mechanism of the Chinese herbal medicinal ingredients of the Xinhuang tablets, is simple and clear; applicable effective drugs can be selected from the known compound medicines by the pharmacological research method.

The invention relates to an ophthalmic pharmaceutical preparation, especially a liposome eye drop preparation containing indomethacin. The composition of the indomethacin liposome eye drop of the invention is: indomethacin, prepared lipid Body fat, buffer solution.

The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese and western medicinal compound preparation for treating acute gastroenteritis and a preparation method thereof. Currently, a chemotherapeutic medicine for treating acute gastroenteritis has the defects of high liver toxicity and poor curative effect in the prior art. The traditional Chinese and western medicinal compound preparation for treating acute gastroenteritis comprises the following components in parts by weight: 10-15 parts of veratrum nigrum, 10-20 parts of notopterygium root, 5-20 parts of sophora japonica, 5-15 parts of scutellaria baicalensis, 5-10 parts of prepared rehmannia, 5-15 parts of lily, 5-15 parts of honeysuckle, 1-10 parts of indometacin, 5-15 parts of medlar, 9-15 parts of costustoot, 9-15 parts of Ligusticum wallichii, 5-15 parts of angelica root, 0.2-9 parts of berberine, 5.5-15 parts of radix paeoniae alba, 6-9 parts of dried ginger, and 10-15 parts of liquorice. The traditional Chinese and western medicinal compound preparation has a good treatment effect on treating or preventing acute gastroenteritis, is low in side effect, and has remarkable clinical application values.

The invention discloses a compound radix angelicae pubescentis transdermal patch used for treating rheumatism and a preparation method thereof. The Chinese herb compound is prepared from radix angelicae pubescentis, angelica sinensis, cassia twigs, ash bark and cyperus rotundus. A volatile oil mixture of the Chinese herb compound is extracted, then a transdermal patch matrix is prepared, the volatile oil extract of the Chinese herb compound, indometacin and borneol are dissolved with 75% ethyl alcohol and then evenly mixed with the matrix, the medicine is evenly applied on a back layer, a polyacrylic resin pressure-sensitive adhesive is smeared around the medicine, the product is covered with release paper and cut to have a regulated area, and the transdermal patch is obtained after sealed packaging. The patch can stop pain rapidly and prevent stimulation to the gastrointestinal tract, the liver and the kidneys from indometacin.

The invention discloses an application of traditional Chinese medicine composition in preparation of a drug for treating osteoarthritis. The traditional Chinese medicine composition comprises traditional Chinese medicines in parts by weight as follows: 600 parts of rhizoma cibotii, 192 parts of fructus rosae fruit, 360 parts of caulis spatholobi, 144 parts of philippine flemingia roots, 360 parts of kadsura coccinea, 240 parts of beautiful millettia roots, 30 parts of glossy privet fruit, 180 parts of mistletoe, 30 parts of semen cuscutae, 26 parts of rhizoma corydalis, 26 parts of radix zanthoxyli, 12 parts of mastic and 20 parts of myrrh. Research demonstrates that the traditional Chinese medicine composition has anti-inflammatory and analgesic effects, has a good inhibiting effect on inflammatory factors causing the osteoarthritis, and is definite in curative effect compared with indometacin and diacerein used clinically. The traditional Chinese medicine composition is used as a traditional Chinese patent medicine and has no adverse effect during decades of clinical use, so that the high-efficiency and low-toxicity treatment drug is provided for patients with the osteoarthritis, and the significant progress is achieved.

The invention discloses quinazolinone derivatives and a production method and application thereof. The quinazolinone derivatives are synthesized by means of the simple and convenient method, the yields are high, the production cost is low, with a concentration of 50 mM and an LPS concentration of 1 <mu>g/mL, the capability of compounds 1a, 1i, 1l and 1n of inhibiting release of NO is superior to that of an anti-inflammatory medicine indometacin, while the capability of 1b, 1e and 1j of inhibiting release of NO is equivalent to that of indometacin; and the cytotoxic effects of the compounds 1a,1i, 1l, 1n, 1b and 1j, with high capability of inhibiting release of NO, on RAW264.7 cells are all lower than that of the anti-inflammatory medicine indometacin. The quinazolinone derivatives have obvious anti-inflammatory effects and very low toxicity, can be made into anti-inflammatory medicines in various dosage forms, and have very high medical values and wide market prospects.

The invention relates to the field of medicines, and particularly relates to a pharmaceutical composition which has anesthetic action in operation. The composition is prepared from 1.0-3.0mg of bupivacaine, 1-5mu g of sufentanil, 15-30mu g of tetrahydropalmatine, 15-30 mu g of indometacin and 0.1-0.5mg of ropivacaine. The anesthetic composition is preferably prepared from 3.0mg of bupivacaine, 3mu g of sufentanil, 20mu g of tetrahydropalmatine, 20mu g of indometacin and 0.3mg of ropivacaine.